We examined associations of CCL2, CCR2, phospho-SMAD3 and phospho-p42/44MAPK with molecular subtype including: luminal A and B, HER2+ and triple negative breast cancers, which were identified using clinical guidelines on ER, PR, HER2 and Ki67/PCNA expression28–30. Here, PCNA is linked to triple-negative breast carcinoma.